Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous anti-NY-ESO-1 mTCR retroviral vector-transduced PBLs

Human autologous peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding both alpha and beta chains of a murine T-cell receptor (mTCR) specific for the cancer-testis antigen NY-ESO-1, with potential antineoplastic activity. Upon isolation, transduction, expansion ex vivo, and reintroduction into the patient, the autologous anti-NY-ESO-1 mTCR retroviral vector transduced PBLs bind to NY-ESO-1 expressed on tumor cells. This may result in cytotoxic T-lymphocyte (CTL)-mediated killing of NY-ESO-1-positive cancer cells. NY-ESO-1, a tumor-associated antigen (TAA), is found in normal testis and on the surface of various tumor cell types.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-NY-ESO-1 mTCR retroviral vector-transduced autologous peripheral blood lymphocytes
autologous anti-NY-ESO-1 Murine TCR retroviral vector-transduced peripheral blood lymphocytes
NY-ESO-1-specific mTCR retroviral vector-transduced autologous PBLs
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search